Connect Biopharma Holdings Ltd is trading at $2.37 (14.1% up) in pre-market as it rebounds from a recent week of mostly declining closes.
- No fresh company-specific headlines, earnings, FDA decisions, or regulatory filings have been identified overnight to explain the move.
- The pre-market strength may reflect improved broader risk appetite and low-liquidity trading, coinciding with higher U.S. equity futures.